These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 15857124)
1. HierS: hierarchical scaffold clustering using topological chemical graphs. Wilkens SJ; Janes J; Su AI J Med Chem; 2005 May; 48(9):3182-93. PubMed ID: 15857124 [TBL] [Abstract][Full Text] [Related]
2. Quantitative structure-antitumor activity relationships of camptothecin analogues: cluster analysis and genetic algorithm-based studies. Fan Y; Shi LM; Kohn KW; Pommier Y; Weinstein JN J Med Chem; 2001 Sep; 44(20):3254-63. PubMed ID: 11563924 [TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and antitumor activity of Novel Sorafenib derivatives bearing pyrazole scaffold. Wang M; Xu S; Lei H; Wang C; Xiao Z; Jia S; Zhi J; Zheng P; Zhu W Bioorg Med Chem; 2017 Oct; 25(20):5754-5763. PubMed ID: 28927801 [TBL] [Abstract][Full Text] [Related]
4. 1-Methyl-3H-pyrazolo[1,2-a]benzo[1,2,3,4]tetrazin-3-ones. Design, synthesis, and biological activity of new antitumor agents. Almerico AM; Mingoia F; Diana P; Barraja P; Lauria A; Montalbano A; Cirrincione G; Dattolo G J Med Chem; 2005 Apr; 48(8):2859-66. PubMed ID: 15828824 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological validation of novel pyrazole derivatives with anticancer activity guided by 3D-QSAR analysis. Vujasinović I; Paravić-Radičević A; Mlinarić-Majerski K; Brajša K; Bertoša B Bioorg Med Chem; 2012 Mar; 20(6):2101-10. PubMed ID: 22341245 [TBL] [Abstract][Full Text] [Related]
6. Synthesis, biological evaluation, and molecular docking studies of N-((1,3-diphenyl-1H-pyrazol-4-yl)methyl)aniline derivatives as novel anticancer agents. Huang XF; Lu X; Zhang Y; Song GQ; He QL; Li QS; Yang XH; Wei Y; Zhu HL Bioorg Med Chem; 2012 Aug; 20(16):4895-900. PubMed ID: 22819191 [TBL] [Abstract][Full Text] [Related]
7. Improving the odds of success in antitumoral drug development using scoring approaches towards heterocyclic scaffolds. Ion GND; Olaru OT; Nitulescu G; Olaru II; Tsatsakis A; Burykina TI; Spandidos DA; Nitulescu GM Oncol Rep; 2020 Aug; 44(2):589-598. PubMed ID: 32627025 [TBL] [Abstract][Full Text] [Related]
8. Forging New Scaffolds from Old: Combining Scaffold Hopping and Hierarchical Virtual Screening for Identifying Novel Bcl-2 Inhibitors. Kanakaveti V; Rathinasamy S; Rayala SK; Gromiha M Curr Top Med Chem; 2019; 19(13):1162-1172. PubMed ID: 31210110 [TBL] [Abstract][Full Text] [Related]
9. Data mining the NCI cancer cell line compound GI(50) values: identifying quinone subtypes effective against melanoma and leukemia cell classes. Marx KA; O'Neil P; Hoffman P; Ujwal ML J Chem Inf Comput Sci; 2003; 43(5):1652-67. PubMed ID: 14502500 [TBL] [Abstract][Full Text] [Related]
10. Synthesis, biological activity, and quantitative structure-activity relationship study of azanaphthalimide and arylnaphthalimide derivatives. Braña MF; Gradillas A; Gómez A; Acero N; Llinares F; Muñoz-Mingarro D; Abradelo C; Rey-Stolle F; Yuste M; Campos J; Gallo MA; Espinosa A J Med Chem; 2004 Apr; 47(9):2236-42. PubMed ID: 15084122 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and Evaluation of 2-Naphthaleno trans-Stilbenes and Cyanostilbenes as Anticancer Agents. Madadi NR; Penthala NR; Ketkar A; Eoff RL; Trujullo-Alonso V; Guzman ML; Crooks PA Anticancer Agents Med Chem; 2018; 18(4):556-564. PubMed ID: 28403783 [TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and biological evaluation of benzo[cd]indol-2(1H)-ones derivatives as BRD4 inhibitors. Feng Y; Xiao S; Chen Y; Jiang H; Liu N; Luo C; Chen S; Chen H Eur J Med Chem; 2018 May; 152():264-273. PubMed ID: 29730189 [TBL] [Abstract][Full Text] [Related]
13. 2-Anilinopyrimidine derivatives: Design, synthesis, in vitro anti-proliferative activity, EGFR and ARO inhibitory activity, cell cycle analysis and molecular docking study. AboulWafa OM; Daabees HMG; Badawi WA Bioorg Chem; 2020 Jun; 99():103798. PubMed ID: 32247112 [TBL] [Abstract][Full Text] [Related]
14. Tagged fragment method for evolutionary structure-based de novo lead generation and optimization. Liu Q; Masek B; Smith K; Smith J J Med Chem; 2007 Nov; 50(22):5392-402. PubMed ID: 17918924 [TBL] [Abstract][Full Text] [Related]
15. Importance of Kier-Hall topological indices in the QSAR of anticancer drug design. Nandi S; Bagchi MC Curr Comput Aided Drug Des; 2012 Jun; 8(2):159-70. PubMed ID: 22497470 [TBL] [Abstract][Full Text] [Related]
16. Design, modification and 3D QSAR studies of novel naphthalin-containing pyrazoline derivatives with/without thiourea skeleton as anticancer agents. Yang W; Hu Y; Yang YS; Zhang F; Zhang YB; Wang XL; Tang JF; Zhong WQ; Zhu HL Bioorg Med Chem; 2013 Mar; 21(5):1050-63. PubMed ID: 23391364 [TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, molecular modeling, and biological evaluation of pyrazole-naphthalene derivatives as potential anticancer agents on MCF-7 breast cancer cells by inhibiting tubulin polymerization. Wang G; Liu W; Peng Z; Huang Y; Gong Z; Li Y Bioorg Chem; 2020 Oct; 103():104141. PubMed ID: 32750611 [TBL] [Abstract][Full Text] [Related]
18. Design and synthesis of 2-phenylnaphthalenoids as inhibitors of DNA topoisomeraseIIα and antitumor agents. Chen W; Shen Y; Li Z; Zhang M; Lu C; Shen Y Eur J Med Chem; 2014 Oct; 86():782-96. PubMed ID: 25240702 [TBL] [Abstract][Full Text] [Related]
19. Structure-Based Design, Synthesis, and Biological Evaluation of Imidazo[4,5-b]pyridin-2-one-Based p38 MAP Kinase Inhibitors: Part 1. Kaieda A; Takahashi M; Fukuda H; Okamoto R; Morimoto S; Gotoh M; Miyazaki T; Hori Y; Unno S; Kawamoto T; Tanaka T; Itono S; Takagi T; Sugimoto H; Okada K; Snell G; Bertsch R; Nguyen J; Sang BC; Miwatashi S ChemMedChem; 2019 May; 14(10):1022-1030. PubMed ID: 30945818 [TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and antitumour activity of bisquinoline derivatives connected by 4-oxy-3-fluoroaniline moiety. Li S; Huang Q; Liu Y; Zhang X; Liu S; He C; Gong P Eur J Med Chem; 2013 Jun; 64():62-73. PubMed ID: 23644189 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]